Accelerated growth and extraordinary customer satisfaction

• Net sales amounted to 18.6 MSEK (13.7), an increase of 36 percent over the same period in 2021.
• Operating result amounted to -3.6 MSEK (-13.6).
• Net result after financial items amounted to -3.7 MSEK (-13.9).
• Earnings per share were -0,06 SEK (-0,21).
• Cash Balance amounted to 6.7 MSEK (21.0).
• Average Daily Treatment Revenue (ADTR)* was 203 TSEK (147), an increase of 38 percent over the same period in 2021.

• Dignitana launched the DigniCap Direct Partner Portal.
• Dignitana appointed Malin Isacsson as Vice President of Sales for Europe.
• Dignitana sponsored signature fundraising events for Susan G. Komen® in Los Angeles and Hair to Stay in San Francisco.

• In October Dignitana announced a directed share issue of approximately 25 MSEK.

• Dignitana CEO Catarina Mård Löwenadler was featured at the Aktiespararna Women's Night in Stockholm.
• Dignitana appointed Johan Johansson as VP Operations, Research and Development.

DIGNITANA GROUP Q3 Q3 Q1-Q3 2022 Q1-Q3 2021 Full year 2021
2022 2021
Net sales, TSEK 18 13 657 52 750 40 860 57 073
602
Total revenues, TSEK 21 13,723 62 428 45,054 62 376
651
Net profit after -3 -13,916 -10 400 -31,240 -43 076
financial items, TSEK 660
Cash and bank balances, 6 737 21,047 6 737 21,047 14 501
TSEK
Earnings per share -0,06 -0,21 -0,16 -0,48 -0,66
before and after
dilution, SEK
Average Daily Treatment 203 147 194 146 147
revenue*, TSEK

* *ADTR includes pay-per-treatment revenue from patients and facilities in the U.S. Does not include lease revenue or disposable sales.

"The fact that nearly ALL Dignitana patients would recommend DigniCap to someone else is an endorsement that we are very proud to receive." - Catarina Löwenadler, CEO Dignitana AB

All financial reports are available at www.dignitana.com/investor-relations/financial-reports/

This disclosure contains information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-11-2022 08:00 CET.